Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Response Assessment for Advanced HCC of Combined SIRT and Immunotherapy Treatment

NCT06971237 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT06971237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06971237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Response Assessment for Advanced HCC of Combined SIRT and Immunotherapy Treatment
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Observational
Overall status
Not yet recruiting
Start date
June 1, 2025
Completion date
July 1, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced hepatocellular carcinoma (hcc), classified as bclc stage b or c, treated with a combination of selective internal radiation therapy